Levis, M., Ravandi, F., Wang, E. S., Baer, M. R., Perl, A., Coutre, S., . . . Smith, B. D. (2011). Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. American Society of Hematology.
Chicago Stili AlıntıLevis, Mark, et al. Results From a Randomized Trial of Salvage Chemotherapy Followed By Lestaurtinib for Patients With FLT3 Mutant AML in First Relapse. American Society of Hematology, 2011.
MLA AlıntıLevis, Mark, et al. Results From a Randomized Trial of Salvage Chemotherapy Followed By Lestaurtinib for Patients With FLT3 Mutant AML in First Relapse. American Society of Hematology, 2011.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..